from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1263/amiB2

LFCtreatmentdescriptionclass of inhibitor

0.320

Amikacinug/mL Amikacintranslation

0.065

Cap5-10ug/mL Capreomycintranslation

-0.136

Rox10-50 ug/mL Roxithromycintranslation

-0.619

SM2-5 ug/mL Streptomycintranslation

0.123

Tet5-10 ug/mL Tetracyclinetranslation

0.491

Rif0.2-5ug/mL Rifampicintranscription

0.657

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.534

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.407

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.482

CPZ10-50 ug/mL Chlorpromazinerespiration

1.599

Clofazimine10-13 ug/mL Clofaziminerespiration

1.269

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.633

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.085

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.054

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.379

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.589

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.625

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.334

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.762

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.398

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.624

Nigericin50 uM Nigericinrespiration

0.656

TRC10-150 ug/mL Triclosanrespiration

1.939

TRZ10-25 ug/mL Thioridazinerespiration

-1.358

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.911

menadione6-10 ug/mL Menadionerespiration

-0.339

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.037

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.126

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.883

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.249

NRP_1Non-replicating persistence stage 1dosRassociated

-0.823

Amp0.2mg/mL AmpicillincellWall

0.141

Cephalexin20-100 ug/mL CephalexincellWall

0.506

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.145

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.397

EMB10-20 ug/mL EthambutolcellWall

0.112

Eta12-40 ug/mL EthionamidecellWall

0.254

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.317

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.041

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.069

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.108

BZA0.12 mg/mL BenzamidearomaticAmides

-0.375

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.546

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.507

H2O24 mM hydrogen peroxideDNAdamaging

0.026

Levo10 ug/mL LevofloxacinDNAdamaging

-0.410

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.512

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.303

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.549

UVUV-irradiationDNAdamaging

1.195

ARP41-4 ug/mL Antitubercular compound ARP4?

0.423

Antimycin12.5-50 ug/mL Antimycin A?

-0.884

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.466

PA_110-50 ug/mL Antitubercular compound PA-1?

0.673

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.926

PA8240.2-2 ug/mL PA-824?

1.013

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.272

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.895

Verapamil50 uM Verapamil?

-0.446

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.467

methoxatin10-20 ug/mL Methoxatin?